📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1. (2019)

First Author: Long-Term Virological Suppression Working Group For The Collaboration Of Observational HIV Epidemiological Research Europe (COHERE) In EuroCoord

Attributed to: Prognosis of HIV-positive patients treated with antiretroviral therapy: comparative analyses and treatment strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000002126

PubMed Identifier: 30829745

Publication URI: http://europepmc.org/abstract/MED/30829745

Type: Journal Article/Review

Volume: 33

Parent Publication: AIDS (London, England)

Issue: 4

ISSN: 0269-9370